MedTrace Logo

Preventing Post-Stroke Depression

NCT00071643 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 201

Last updated 2017-09-05

No results posted yet for this study

Summary

This study will evaluate the effectiveness of both drug and non-drug treatments in preventing depression after a stroke.

Conditions

Interventions

BEHAVIORAL

Problem Solving Therapy

Problem solving therapy aims to make patients aware of symptoms of problems and link those with behaviors associated with solving them.

DRUG

Escitalopram

Participants will receive escitalopram, a selective serotonin reuptake inhibitor.

OTHER

Placebo

Participants will receive a placebo pill.

Sponsors & Collaborators

  • National Institute of Mental Health (NIMH)

    collaborator NIH

  • Robert G. Robinson

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
31 Years
Max Age
89 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2002-09-30
Primary Completion
2008-11-30
Completion
2008-11-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00071643 on ClinicalTrials.gov